Parallel Health is proud to announce that Co-Founder and CEO Natalise Kalea Robinson has been named to Inc.'s 2026 Female Founders 500, an annual list honoring the most dynamic women business leaders in the United States. The recognition celebrates founders whose bold ideas, resilience, and execution are shaping the future of their industries.

This year's honorees collectively generated approximately $12.3 billion in revenue in 2025 and $12.2 billion in funding to date, reflecting the broad economic impact of women-led businesses across sectors. Previous honorees have included Billie Jean King, Sallie Krawcheck, Serena Williams, and Emma Grede.

A Founder Who Has Never Taken the Expected Path

Born and raised in San Francisco, Natalise grew up between a love of physics and a passion for music. During her sophomore year at Stanford, she was signed to a record label, left astrophysics, graduated early, and toured the United States. Years later, after building companies in media, marketing, and wellness and returning to Stanford for her MBA, she co-founded Parallel Health, bringing the same creative rigor and grit she developed as an artist to one of medicine's most underexplored frontiers.

She arrived at biotech through a deep conviction that the microbiome holds answers to some of the most complex, chronic diseases, and that someone needed to build the platform to find them.

"Being a founder building in cutting-edge biotech means creating the map as you go," said Robinson. "We built Parallel Health and are pioneering Microbiome Dermatology™ because the skin microbiome holds answers medicine hasn't found, answers that reach into longevity and chronic disease. I'm grateful to represent myself and Parallel in this honor."

Building a New Category in Medicine

As Co-Founder and CEO, Robinson has built Parallel Health into a vertically integrated precision health platform spanning telehealth, microbial genomic analysis, proprietary AI, in-house manufacturing, personalized compounded prescriptions, and therapeutic discovery. Under her leadership, Parallel has secured eight patents pending, developed a biobank of over 10,000 characterized microbial strains, and earned in-network status with Aetna and Cigna in California.

From the beginning, building Parallel Health has required grit because we're doing something genuinely hard: bringing rigorous skin microbiome science into clinical care and making it accessible to real patients. Robinson has been clear that the skin is just the beginning. Parallel's platform is designed to address any condition where the microbiome plays a role, from chronic disease to longevity.

What Inc. Had to Say

"Each year, we are increasingly amazed by the extraordinary leaders on our Inc. Female Founders 500 list," said Bonny Ghosh, editorial director at Inc. "The honorees on this year's list include innovators in AI, beauty and wellness trendsetters winning devoted fans, and nonprofit leaders making a real impact in their communities. Together, they're showing all of us what trailblazing female leadership looks like."

Several honorees will be featured in Inc. magazine's Spring print issue, on newsstands March 17, 2026.

To see the complete list of 2026 Female Founders 500 honorees, visit inc.com/female-founders/2026.